CLDI

CLDI

USD

Calidi Biotherapeutics Inc. Common Stock

$0.240-0.014 (-5.433%)

Reaalajas hind

Healthcare
Biotehnoloogia
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$0.254

Kõrge

$0.260

Madal

$0.225

Maht

0.55M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

7.6M

Tööstusharu

Biotehnoloogia

Riik

United States

Kauplemisstatistika

Keskmine maht

0.78M

Börs

ASE

Valuuta

USD

52 nädala vahemik

Madal $0.203Praegune $0.240Kõrge $3.89

Seotud uudised

PR Newswire

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs

An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year worldwide...

Vaata rohkem
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
PR Newswire

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs

An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year worldwide...

Vaata rohkem
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
GlobeNewswire

Calidi Biotherapeutics Announces Shareholder Letter from CEO

SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE:CLDI) ("Calidi"), a clinical-stage biotechnology company pioneering the development of systemic oncolytic targeted immunotherapies with the

Vaata rohkem
Calidi Biotherapeutics Announces Shareholder Letter from CEO

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.